Navigation Links
Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease
Date:5/16/2008

ch as fatigue, skin rash, anemia, fertility issues, joint pain, weight loss, pale sores inside the mouth, tooth discoloration or loss of enamel, depression, chronic diarrhea or constipation, gas and abdominal pain. The immunology and nutritional abnormalities in celiac disease can potentially result in long-term complications such as osteoporosis, refractory sprue, small intestinal cancer, and lymphoma. The only current treatment for CD is complete elimination of gluten from the diet, which results in remission for most patients, but can be very difficult to implement in practice. "However, the response to the gluten-free diet is poor in up to 30% of patients and dietary nonadherence is the chief cause of persistent or recurrent symptoms."(1)

About "Larazotide Acetate"

Larazotide acetate is an experimental medicine and an inhibitor of barrier dysfunction that has been shown to block abnormally increased intestinal permeability and the genesis of some autoimmune diseases, either as a result of reduction of antigen presentation to the body's immune system, or through inhibitory, direct effects on gastrointestinal associated lymphoid tissue. Larazotide acetate is orally formulated, has been granted "Fast Track" designation by the U.S. Food and Drug Administration for the treatment of celiac disease, and is also being evaluated for the treatment of Crohn's Disease. Results of the Company's first study in celiac patients are available online at: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2036.2007.03413.x

About Alba

Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies to treat autoimmune and inflammatory diseases and is located in Baltimore, Maryland. Alba's technology platform is based upon a key pathway that regulates
'/>"/>

SOURCE Alba Therapeutics Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results
2. Cell Therapeutics, Inc. (CTI) to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
3. Nile Therapeutics Reports 2008 First Quarter Financial Results
4. Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
5. Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI)
6. Amicus Therapeutics Announces First Quarter 2008 Financial Results
7. Nile Therapeutics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
8. Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
9. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference
10. TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast
11. Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...ALGARY, July 25 / Resverlog...) is pleased to announce effective,immediately Jan...ors. On,the subject of her appointment Jan Gray sa...ng opportunity for me. The Company has done a wond...al trials. I expect the next,foreseeable future to...
(Date:7/25/2008)...s Company,s IPLEX(TM) Program in Myotonic ...a., July 25 /- Insmed Inc. ...and biopharmaceuticals, today,announced that Geoff...BC,s,13th Annual Drug Discovery and Development of...2008 at 9:25 AM ET., Dr. Allan will be participat...
(Date:7/25/2008)...nt survey on creativity, sponsored by the Jerusale...NS Teleseker, revealed that a majority of the Isra...se special methods that could "put them into ...s long as desired." , ...ent survey on creativity, sponsored by the Jerusal...
(Date:7/24/2008)...uct Sales Driven by Robust MRSA Growth, SUNNYVALE...d (Nasdaq:,CPHD) today reported revenue for the se... of 55% over the second quarter of fiscal 2007. Ne...ch compares to revenue of,$27.2 million and a net ...,second quarter of fiscal 2007., Excluding amorti...
Breaking Biology Technology:Jan Gray Joins Resverlogix Board of Directors 2Insmed CEO to Present at Drug Discovery & Development Conference 2Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 2Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 3Cepheid Reports Second Quarter Revenue of $42.1 Million 2Cepheid Reports Second Quarter Revenue of $42.1 Million 3Cepheid Reports Second Quarter Revenue of $42.1 Million 4Cepheid Reports Second Quarter Revenue of $42.1 Million 5Cepheid Reports Second Quarter Revenue of $42.1 Million 6Cepheid Reports Second Quarter Revenue of $42.1 Million 7Cepheid Reports Second Quarter Revenue of $42.1 Million 8Cepheid Reports Second Quarter Revenue of $42.1 Million 9Cepheid Reports Second Quarter Revenue of $42.1 Million 10Cepheid Reports Second Quarter Revenue of $42.1 Million 11Cepheid Reports Second Quarter Revenue of $42.1 Million 12Cepheid Reports Second Quarter Revenue of $42.1 Million 13
...portal to educational information about books and ...ward from the Association of Educational Publishe...evement in supplemental educational resources for ...in the Best Educational Website category titled "P...s.net is a provider of multimedia resources that s...
...t Corp. has closed on loans to help two Madison t...Universal Separators, Inc. , stretch scarce ventur...ture Debt Fund established earlier this year by MD...hard-to-finance small businesses. , ,A $200,000 l...t its data extraction and redaction software. The ...
...I have a number of juicy topics I wanted to review...e annual Israel biotech/medical device conference ...out Indian and my growing insights into the Indian...search that has crossed my transom (including musi...inally wanted to start writing this column. I real...
...lark CEO Darwin Smith may or may not have brought...e. , ,It was 1983, and Wisconsin had just elected ...pted to address a budget deficit with an income ta...the impact of high taxes on the state,s business c...lark,s corporate headquarters to Dallas, although ...
Other Biology Technology:MDC provides venture funding for tech companies 2The world of in vitro diagnostics is another Midwest success story 2The world of in vitro diagnostics is another Midwest success story 3The world of in vitro diagnostics is another Midwest success story 4The world of in vitro diagnostics is another Midwest success story 5The world of in vitro diagnostics is another Midwest success story 6RedPrairie: Will they stay, or will they go? 2RedPrairie: Will they stay, or will they go? 3RedPrairie: Will they stay, or will they go? 4
(Date:7/25/2008)...rsity of Houston department of health and human pe...econd Life (SL) thanks to grants from the UH Facul...etwork Culture Project of the University of Southe..., "These funds will allow our faculty to stake g...ts and our community," said Charles Layne, profess...
(Date:7/25/2008)...the need to translate basic science discoveries i...ew study by researchers at the Medical College of ...f Health (NIH) identified reasons why clinical sc...r reviews than basic science grant applications to...issue of The American Journal of Medicine . , I...
(Date:7/25/2008)...July 25, 2008) New research published in the July...Surgeons shows elevated plasma DNA is a reliable ...lso suggests that plasma DNA levels rise before cl...ty of patients. , Esophageal cancer, one of th...ally diagnosed at a late stage. An accurate marker...
(Date:7/24/2008)...nstitutional team led by Massachusetts General Hos... new tool for genomic research and medicine a rob...an target particular DNA sequences for inactivatio...Cell, the researchers describe an efficient, publ...finger nucleases (ZFNs), which can be used to indu...
Breaking Biology News(10 mins):Second Life a first for UH department of health and human performance 2New study spotlights National Institutes of Health grant outcomes for clinical research 2Plasma DNA level is a reliable marker of recurrent esophageal cancer, study finds 2Consortium develops new method enabling routine targeted gene modification 2Some Iraq War Vets Suffer Breathing Problems 19978 1Some Iraq War Vets Suffer Breathing Problems 19978 2Some Iraq War Vets Suffer Breathing Problems 19978 3The Quantum Group Completes Corporate Expansion Plan 3B Employee and Corporate Office Growth Leads the Way for Enhanced Innovation and Growth Through 19974 1The Quantum Group Completes Corporate Expansion Plan 3B Employee and Corporate Office Growth Leads the Way for Enhanced Innovation and Growth Through 19974 2The Quantum Group Completes Corporate Expansion Plan 3B Employee and Corporate Office Growth Leads the Way for Enhanced Innovation and Growth Through 19974 3ACM Taps Two Senior Leaders to Head Up New Strategic Initiatives 19970 1ACM Taps Two Senior Leaders to Head Up New Strategic Initiatives 19970 2Dendreon Presents Preclinical Data Demonstrating Activity of Trp p8 agonist D 3263 in Benign Prostatic Hyperplasia 2155 1Dendreon Presents Preclinical Data Demonstrating Activity of Trp p8 agonist D 3263 in Benign Prostatic Hyperplasia 2155 2Dendreon Presents Preclinical Data Demonstrating Activity of Trp p8 agonist D 3263 in Benign Prostatic Hyperplasia 2155 3Dendreon Presents Preclinical Data Demonstrating Activity of Trp p8 agonist D 3263 in Benign Prostatic Hyperplasia 2155 4
...dely touted as an eco-friendly, clean-burning fuel... fuel made primarily from ethanol instead of pure ... and hospitalizations would likely increase, accor...eric scientist Mark Z. Jacobson. His findings are ...urnal Environmental Science & Technology (ES&a...
...ancer Institute researchers have developed a power...regulating molecules called nucleosomes throughout...over important clues for understanding and diagnos... Moreover, it may shed light on the role of nucleo...ell to its original embryonic state, which is a cr...
...stematic Review of the use of electronic mosquito ... they work. The researchers therefore say that the...at there is no reason for even trying to do more r... when a person is bitten by an infected female mos...ents (EMRs) claim that the high pitch sound they e...
...gned to emulate the healing power of the sun could...te cancer as early as 2009. But it remains to be s...state cancer care that its makers claim. , The dr... given to patients in the advanced stages of prost...kers came up with the idea because vitamin D from ...
Other Biology News:Ethanol vehicles pose a significant risk to human health, study finds 2Ethanol vehicles pose a significant risk to human health, study finds 3Scientists map key landmarks in human genome 2Scientists map key landmarks in human genome 3Sunshine pill for prostate cancer in 2009 2
...ash microplate washer 100-240 V, is used for washi...ottom wells. The immunowash microplate washer has ...positions to an accuracy of 0.1 mm for bottom wash...t can store up to 75 wash sequences for customized...
... a compact benchtop and stackable multi-function i... a large display screen to accurately control temp...e to evenly distribute temperature in the incubato...icroprocessor controller. Built in maintenance-fre...
... a compact benchtop and stackable multi-function i... a large display screen to accurately control temp...e to evenly distribute temperature in the incubato...icroprocessor controller. Built in maintenance-fre...
siTrio siRNA --- a cocktail of 3 siRNAs specifically targeted to your target gene of interestis our most popular product. The siTrio reagent guarantees you get more than 75% knockdown of your target
Biology Products: